FENNEC PHARMACEUTICALS INC financial statements, including revenue, expenses, profit, and loss

The total revenue of FRX for the last quarter is 34.22 M CAD, and it's 158.11% higher compared to the previous quarter. The net income of Q1 24 is 17.31 M CAD.